The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This ...

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

IN line with President Ferdinand Marcos, Jr.'s assurance of continuous expansion in health care benefits despite zero subsidy ...

In line with President Ferdinand Marcos Jr.'s assurance of continuous expansion in healthcare benefits despite zero subsidy, the Philippine Health Insurance Corporation (PhilHealth) has substantially ...

The Philippine Health Insurance Corporation (PhilHealth) has substantially enhanced its Z Benefit Package for Peritoneal ...

The Philippine Health Insurance Corporation (PhilHealth) announced that it has significantly enhanced its Z Benefit Package ...

Pediatric patients can receive P510,000 to P765,210 for CAPD and P763,000 to P1.2 million for APD. The package also includes coverage for related services like infection prevention and treatment for ...

Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...

We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial ...

CGMs can also be used with insulin pump therapy. A sensor-augmented pump (SAP) combines the technology of an insulin pump with a continuous glucose sensor, allowing users to monitor glucose and ...

The trial is assessing the efficacy and safety of the company's selective cytopheretic device (SCD) in conjunction with ...